- Home
- ELBM vs FEMY Comparison
ELBM vs FEMY Comparison
Compare ELBM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELBM
- FEMY
- Stock Information
- Founded
- ELBM 2011
- FEMY 2004
- Country
- ELBM Canada
- FEMY United States
- Employees
- ELBM N/A
- FEMY N/A
- Industry
- ELBM Industrial Machinery/Components
- FEMY Medical/Dental Instruments
- Sector
- ELBM Miscellaneous
- FEMY Health Care
- Exchange
- ELBM Nasdaq
- FEMY Nasdaq
- Market Cap
- ELBM 16.7M
- FEMY 18.6M
- IPO Year
- ELBM N/A
- FEMY 2021
- Fundamental
- Price
- ELBM $0.86
- FEMY $0.38
- Analyst Decision
- ELBM Strong Buy
- FEMY Strong Buy
- Analyst Count
- ELBM 1
- FEMY 3
- Target Price
- ELBM $2.20
- FEMY $7.33
- AVG Volume (30 Days)
- ELBM 130.6K
- FEMY 1.6M
- Earning Date
- ELBM 08-15-2025
- FEMY 08-08-2025
- Dividend Yield
- ELBM N/A
- FEMY N/A
- EPS Growth
- ELBM N/A
- FEMY N/A
- EPS
- ELBM N/A
- FEMY N/A
- Revenue
- ELBM N/A
- FEMY $1,887,016.00
- Revenue This Year
- ELBM N/A
- FEMY $103.55
- Revenue Next Year
- ELBM N/A
- FEMY $148.13
- P/E Ratio
- ELBM N/A
- FEMY N/A
- Revenue Growth
- ELBM N/A
- FEMY 98.61
- 52 Week Low
- ELBM $0.77
- FEMY $0.31
- 52 Week High
- ELBM $2.70
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- ELBM 26.53
- FEMY 24.33
- Support Level
- ELBM $0.84
- FEMY $0.36
- Resistance Level
- ELBM $0.93
- FEMY $0.42
- Average True Range (ATR)
- ELBM 0.07
- FEMY 0.06
- MACD
- ELBM -0.01
- FEMY -0.01
- Stochastic Oscillator
- ELBM 26.15
- FEMY 16.48
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.